B3PK30 AF NFT

DNA-directed RNA polymerase subunit beta

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeifijfbicc7lpx7rf3eg4zwzy4lk6nzixsslsr7svys44zcjchc64q/metadata.json
IPFS of structure file: 
bafybeicp4mc4aced26h3kba3dcedyhtk5hrjpwzxwgkuh4wvtbicusczj4/AF-B3PK30-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x4eB83b6340c032CC7AcdbC262D37E9627F422205
First NFT owner address (bech32): 
genesis1f6urkc6qcqevc7kdhsnz6dlfvfl5ygs9kgldax
Current NFT ID #387120 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
387120
Accession (UniProt):
B3PK30
Name::
DNA-directed RNA polymerase subunit beta
Experimental Method:
Predicted structure
Sequence source:
CELLVIBRIO JAPONICUS (STRAIN UEDA107)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B3PK30 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B3PK30|RPOB_CELJU DNA-directed RNA polymerase subunit beta OS=Cellvibrio japonicus (strain Ueda107) OX=498211 GN=rpoB PE=3 SV=1 MAYSYTEKKRIRKNFGKLPHVMDVPYLLAIQLDSYRKFTQADLSANKREDVGLHAAFRSVFPIVSYSGNAALEYVSYSLGKAAFDVNECILRGVTYAVPLRVKVRLIIYDRESANKAIKDIKEQEVYMGEIPLMTDNGTFVINGTERVIVSQLHRSPGVFFDHDKGKTHSSGKLLYSARIIPYRGSWLDFEFDPKDLLYVRIDRRRKLPATILLRALNYSSQEMLSMFFETSSFTLGKDGQFSYEVVPSRLRGDVATFDIKDDKGNIIVEEGRRITARHIRQLEKAGVDQMEVPSEYLLGRSLAKDIVDTRTGELLFECNTEITSDVLSKIVAAGVEKVETLYTNELDCGPFISETLRIDPTRTQLEALVEIYRMMRPGEPPTKESAEALFQNLFFSQERYDLSAVGRMKFNRRLGRETETGEGTLSNDDIVDVMKTLISIRNGKGVVDDIDHLGNRRVRSVGEMAENQFRVGLVRVERAVKERLSMAESEGLMPQDLINAKPVAAAVKEFFGSSQLSQFMDQNNPLSEITHKRRVFALGPGGLTRERAGFEVRDVHPTHYGRVCPIETPEGPNIGLINSLATYARTNNYGFLESPYRKVIEGKVTDQIEYLSAINESEYVIAQASASLDDNGRLTEELVSVRHQNEFTLKAPTDVQYMDVSARQVVSVAASLIPFLEHDDANRALMGSNMQRQAVPTLRSQKPLVGTGMERNVAADSGVCVVAKRGGVIDSVDAGRIVVKVHDAEVEAGDAGVDIYNLIKYTRSNQNTCINQRPIVSMGDIVSRGDILADGPSVDMGELALGQNMRIAFMPWNGYNFEDSILVSERVVQEDRFTTIHIQELTCIARDTKLGSEEITADIPNVGESALSKLDESGIVYIGAEVGGGDILVGKVTPKGETQLTPEEKLLRAIFGEKASDVKDTSLRVPSGTKGTVIDVQVFTRDGLEKDQRSLEIEKAQLDEVRKDLNEEFRIVETATFERLRAALVGQIVASGKGVKKGEALTHDILDGLEKDQWFKLRMNEDALNEQIDRAEEQLAERRKILDERFEDKKRKLSTGDDLAPGVLKIVKVYLAIKRRIQPGDKMAGRHGNKGVISVIMPVEDMPYDENGETVDIVLNPLGVPSRMNVGQVLEMHLGMAAKGLGVKINKLIQEQKAVADIRSFLEEIYNSTGDVAAKEDLVSFSDREVIDLAKNLVDGVPMATPVFDGAKEHEIKALLRLASLSDTGQTTLFDGRTGDQFSRSVTVGYMYMLKLNHLVDDKMHARSTGSYSLVTQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVAGRTKMYKNIVDGDHRMEPGMPESFNVLVKEIRSLGINIELEQED